Ilya Shestopalov | Associate Director, Cell Analytics
bluebird bio

Ilya Shestopalov, Associate Director, Cell Analytics, bluebird bio

Ilya Shestopalov, PhD currently leads the cell analytics group within cellular process development at bluebird bio.  His research focuses on development of cell-based assays for hematopoietic stem/progenitor and CAR-T products.  Prior to bluebird bio, Dr. Shestopalov was a postdoctoral fellow in stem cell biology at Boston Children’s Hospital and Harvard University working with zebrafish hematopoietic stem cells.  Dr. Shestopalov received his PhD in 2010 from the Chemical Biology program at Stanford University and a BS in Biological Chemistry from University of Chicago.


Conference Day 1 - Tuesday 31st March 2020 @ 15:40

Lessons learned from potency assays for beta-thalassemia and sickle cell disease autologous gene therapy drug products

Conference Day 1 - Tuesday 31st March 2020 @ 17:20

Panel discussion (potency + assays): Predictive clinical functionality - guaranteeing the success of your cell therapy product

last published: 06/Dec/19 09:35 GMT

back to speakers